17-21 June 2017 Copenhagen
1-P | THALASSEMIA CARE IN DHAKA-2016A RETROSPECTIVE, OBSERVATIONAL STUDY OF CHILDREN ATTENDING IN TWO MAJOR THALASSEMIA CENTRES IN DHAKA, BANGLADESHA LOW INCOME COUNTRIES PERSPECTIVE | Amin Islam | Received |
7-P | LEBANESE RED CROSS BLOOD TRANSFUSION SERVICES: SCALING UP ITS ACTIVITIES TO SATISFY BLOOD NEEDS OF SYRIAN REFUGEES AND HOST POPULATION IN LEBANON | Claudio Zaugg | Received |
12-P | THE QUANTITATIVE SWOT-ANALYSIS OF ACTIVITY SERVICE BLOOD OF KAZAKHSTAN | Talgat Issayev | Received |
13-P | IMPLEMENTATION OF COMPUTERIZED BLOOD BANK MANAGEMENT SYSTEMS IN FIVE DEVELOPING SETTINGS: LESSONS LEARNED | Tonderai Mapako | Received |
16-P | THE RIGHT BLOOD FOR THE RIGHT PATIENT: BRINGING INNOVATION AND TECHNOLOGY TOGETHER | Manuel Algora | Received |
18-P | VALIDATION OF MULTISOURCE ELECTRONIC HEALTH RECORD DATA: AN APPLICATION TO BLOOD TRANSFUSION DATA | Mart Janssen | Received |
26-P | TEACHING WITHOUT BORDERS: USING ELEARNING TO IMPROVE CLINICAL TRANSFUSION PRACTICE IN THE DEVELOPING WORLD | David Peterson | Received |
27-P | THE ROLE OF ELEARNING IN IMPROVING TRANSFUSION PRACTICE AND IMPLEMENTING PBM | David Peterson | Received |
31-P | DEVELOPMENT OF ORIENTATION PROGRAMME IN BLOOD DONATION AS PART OF KNOWLEDGE MANAGEMENT | Piia Korkalainen | Received |
38-P | PHENOTYPED RED CELLS MEETING INCREASED DEMAND | Tanya Powley | Received |
80-P | A WEB-BASED APPROACH TO BLOOD DONOR MANAGEMENT IN HOSPITAL BLOOD BANK | Svetlana Trofimova | Received |
86-P | RETROSPECTIVE ANALYSIS OF CAPILLARY HEMOGLOBIN RECOVERY IN NEARLY 1 200 000 BLOOD DONOR RETURNS | Mikko Arvas | Received |
87-P | THE INFLUENCE OF TELEPHONE CONTACTING ON THE RETURN OF FIRST-TIME DONORS | Anu Keisala | Received |
126-P | CAN HISTORICAL DONOR PLATELET COUNTS RESULTS BE USED FOR PROGRAMMING PLATELET DONATION? | Phillip Mondy | Received |
127-P | FIFTY YEARS OF RHD IMMUNOGLOBULIN THERAPY IN AUSTRALIA | Tanya Powley | Received |
130-P | BLOOD DONORS PERCEPTION ON ABO BLOOD TYPE BASED MANAGEMENT AND ITS INFLUENCE ON INTENTION TO DONATE | Elina Palokangas | Received |
142-P | COLLECTION OF BLOOD COMPONENTS BY APHERESIS IN THE RUSSIAN FEDERATION | Alexander Chechetkin | Received |
146-P | IMPROVING SAFETY AND ENHANCING THE DONATION EXPERIENCE FOR APHERESIS DONORS | Barbara Bell | Received |
147-P | 11 OF FINNISH BLOOD DONOR HAVE IRON DEFICIENCY BUT THEIR SELF-REPORTED SUBJECTIVE HEALTH IS NOT AFFECTED | Pia Niittymki | Received |
156-P | THE CRUCIAL ROLE OF BLOOD COLLECTION STAFF IN PREVENTING AND MANAGING VASOVAGAL REACTIONS | Amanda Thijsen | Received |
168-P | MAXIMISING PLATELET USAGE BY DELAYING REFRIGERATED STORAGE | Denese Marks | Received |
197-P | IMPROVED BACTERIAL DETECTION ALGORITHM SUPPORTS EXTENSION OF PLATELET STORAGE FROM 5 TO 7 DAYS AT CANADIAN BLOOD SERVICES | Sandra Ramirez-Arcos | Received |
201-P | CRYOPRESERVED PLATELETS DEMONSTRATE A REDUCED RESPONSE TO COLLAGEN STIMULATION | Denese Marks | Received |
208-P | FIVE YEARS FOLLOW UP OF BLOOD PRODUCTS QUALITY CONTROL AT THE ETABLISSEMENT FRANAIS DU SANG, THE FRENCH TRANSFUSION PUBLIC SERVICE | Stephane Bégué | Received |
212-P | NUMERICAL INVESTIGATION OF RED BLOOD CELL MEMBRANE MECHANICAL PROPERTIES AND DEFORMABILITY DURING INDENTATION | Sarah Barns | Received |
219-P | CORRELATION BETWEEN ABSENCE OF SWIRLING IN PLATELETS CONCENTRATES AND BIOCHEMICAL CHANGES IN METABOLISM | Nicolas de Valensart | Received |
224-P | EVIDENCE BASED PRACTICE OF FRESH FROZEN PLASMA REPEAT FREEZE THAW | Hanna Morani | Received |
244-P | OXYGEN CONTENT--UNCONTROLLED AND OVERLOOKED PARAMETER ASSOCIATED WITH STORED RED CELL CONCENTRATE QUALITY: UNEXPECTEDLY WIDE DISTRIBUTION | Tatsuro Yoshida | Received |
250-P | CHARACTERIZATION OF INTERCEPT BLOOD SYSTEM FOR RED BLOOD CELLS USING SAGM RBCS PREPARED USING MANUAL AND AUTOMATED WHOLE BLOOD SEPARATION TECHNIQUES | Lynn Annandale | Received |
252-P | INACTIVATION OF BIOFILM-DERIVED STAPHYLOCOCCUS EPIDERMIDIS IN PLATELET CONCENTRATES WITH RIBOFLAVIN AND ULTRAVIOLET LIGHT TREATMENT | Sandra Ramirez-Arcos | Received |
254-P | RED BLOOD CELL CONCENTRATES TREATED WITH THE AMUSTALINE (S-303) PATHOGEN REDUCTION SYSTEM RETAIN ERYTHROCYTE MORPHOLOGY AND METABOLIC PROPERTIES | Catherine RAVANAT | Received |
256-P | ROBUSTNESS OF THE INTERCEPT BLOOD SYSTEM FOR RED BLOOD CELLS | Lynn Annandale | Received |
258-P | ZIKA VIRUS INFECTIVITY IS REDUCED FOLLOWING TREATMENT WITH THE THERAFLEX UVC-PLATELET AND THERAFLEX MB-PLASMA SYSTEMS | Denese Marks | Received |
259-P | EVALUATION OF APHERESIS PLATELETS PROCESSED WITH THE INTERCEPT BLOOD SYSTEM FOR PLATELETS TRIPLE STORAGE SET | Lynn Annandale | Received |
262-P | EVALUATION OF PATHOGEN REDUCED (AMOTOSALEN-UVA) POOLED CRYOPRECIPITATE AND CRYOPRECIPITATE-POOR PLASMA | Lynn Annandale | Received |
269-P | FEASIBILITY TEST OF DOUBLE DOSES PATHOGEN-REDUCED PLATELET COMPONENTS BY INTERCEPT BLOOD SYSTEM AFTER SEPARATION FROM WHOLE BLOOD BY REVEOS AUTOMATED BLOOD PROCESSING SYSTEM | Mohammad Reza Abedi | Received |
273-P | EFFECTIVENESS OF AMOTOSALEN/UVA LIGHT PATHOGEN-REDUCED PLATELETS TRANSFUSED TO ADULT PATIENTS | Railya Ayupova | Received |
275-P | EFFECTIVE PATHOGEN INACTIVATION IN TRIPLE SET KITS FOR PLATELETS SUSPENDED IN PLATELET ADDITIVE SOLUTION (PASIII) | Lynn Annandale | Received |
277-P | PRODUCTION AND QUALITY OF ALLOGENEIC PLATELET GEL PRODUCED BY PRECIPITATION OF EXPIRED APHERESIS PLATELET CONCENTRATES | Denese Marks | Received |
278-P | AUTOLOGOUS SERUM EYE DROPS: FIVE YEARS EXPERIENCE OF MANUFACTURING AND APPLICATION | Melanie Strmer | Received |
288-P | ROBUSTNESS OF THE ABBOTT PRISM METHODS TO BIOTIN INTERFERENCE | Lynn Martin | Received |
289-P | SPECIFICITY OF AUTOMATED BLOOD SCREENING ASSAYS DEVELOPED FOR THE NEW ABBOTT ALINITY S SYSTEM | Lynn Martin | Received |
293-P | PERFORMANCE CHARACTERISTICS OF THE 4 SCREENING ASSAYS, HBSAG QUALITATIVE II, ANTI-HCV, HIV AG/AB COMBO AND SYPHILIS TP ON ABBOTTS NEW ALINITY I SYSTEM | Angela Vockel | Received |
331-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR HEPATITIS B SURFACE ANTIGEN AND HEPATITIS B SURFACE ANTIGEN CONFIRMATORY ON THE ALINITY S SYSTEM | Lynn Martin | Received |
336-P | PERFORMANCE OF NEW AUTOMATED IMMUNOASSAY ASSAY FOR ANTI-HBC ON THE ALINITY S SYSTEM | Lynn Martin | Received |
339-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTI-HCV FOR THE ALINITY S SYSTEM | Lynn Martin | Received |
363-P | PERFORMANCE OF NEW AUTOMATED IMMUNOASSAY ASSAY FOR HIV ON THE ALINITY S SYSTEM | Lynn Martin | Received |
368-P | PERFORMANCE OF A NEW AUTOMATED IMMUNOASSAY FOR THE DETECTION OF SYPHILIS ON THE ALINITY S SYSTEM | Lynn Martin | Received |
375-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTIBODIES TO T. CRUZI ON THE ALINITY S SYSTEM | Lynn Martin | Received |
379-P | PERFORMANCE AND EVALUATION OF PROCLEIX ZIKA VIRUS ASSAY ON THE FULLY AUTOMATED PROCLEIX PANTHER SYSTEM | Kui Gao | Received |
386-P | ROBUST INACTIVATION OF DUCK HEPATITIS B VIRUS WITH AMUSTALINE/GSH IN WHOLE BLOOD | Lynn Annandale | Received |
389-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTIBODIES TO CMV ON THE ALINITY S SYSTEM | Lynn Martin | Received |
397-P | PERFORMANCE OF A NEW AUTOMATED IMMUNOASSAY FOR THE DETECTION OF HTLV I AND HTLV II ON THE ALINITY S SYSTEM | Lynn Martin | Received |
402-P | PREVENTING EMERGING AND CO-CIRCULATING TRANSFUSION-TRANSMITTED ARBOVIRUS INFECTIONS | didier musso | Received |
404-P | HEPATITIS E VIRUS INFECTION: INCIDENCE AND EPIDEMIOLOGICAL CHARACTERISTICS OF POSITIVE BLOOD DONORS IN CATALONIA (SPAIN) | Maria Piron | Received |
414-P | A NOVEL ADJUNCT AUTOMATED BLOOD BANK METHOD TO MANAGE INTERFERENCE FROM THE MONOCLONAL ANTI-CD38 DRUG DARATUMUMAB. | Glenda Mann | Received |
450-P | PREDICTING ANTI-RHD TITERS IN DONORS: BOOSTERING RESPONSE AND DECLINE RATES ARE PERSONAL | Mart Janssen | Received |
453-P | DEVELOPMENT AND APPLICATION OF ETERNAL BLOOD GROUP ANTIGENS INDEPENDENT OF LIVING RED CELLS | Shengbao Duan | Received |
462-P | THE MDMULTICARD FOR TYPING FYA, FYB, JKA, JKB, S, AND LITTLE S WAS SUPERIOR TO THE TUBE METHOD | Christof Weinstock | Received |
474-P | EVALUATION STUDY OF THE ERY SPOT WEAK D-TYPE GENOTYPING ASSAY ON THE MR.SPOT PROCESSOR | rolf marell | Received |
501-P | AN RHDC.1066 INS A MUTATION INDUCES PARTIAL D REACTIVITY | Brigitte Flesch | Received |
511-P | A THIRD ABO ALLELE IN A PATIENT WITH TRISOMIE 9 | Brigitte Flesch | Received |
513-P | AN ABO MOLECULAR TYPING ENIGMA | Franz Wagner | Received |
519-P | A FUT1C.787INSA MUTATION INDUCES A PREMATURE STOP AND THE BOMBAY (H-) PHENOTYPE | Brigitte Flesch | Received |
526-P | A NOVEL KLF1 ALLELE LEADING TO AN IN(LU) PHENOTYPE | Christine Henny | Received |
552-P | THE DETECTION OF MATERNAL HPA-1A ANTIBODIES AND THEIR ROLE IN PREDICTING THE SEVERITY OF FNAIT: A SYSTEMATIC REVIEW | Denise Landry | Received |
586-P | RED BLOOD CELL ANTIBODIES AND HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN IN ISRAEL WHAT IS THE EVIDENCE? | Naomi Rahimi-Levene | Received |
588-P | FETOMATERNAL RED BLOOD CELLS ALLOIMMUNIZATION AND UNIVERSAL CORD BLOOD SCREENING AT BIRTH: ONE-CENTER EXPERIENCE | Elena Lazarova | Received |
589-P | ANALYSIS OF PEDIATRIC ADVERSE REACTIONS TO TRANSFUSIONS (APART) | Sarah Vossoughi | Received |
621-P | INCREASING PREVALENCE OF ANEMIA AFTER HOSPITAL DISCHARGE AND LONG TERM CLINICAL OUTCOMES | Nareg Roubinian | Received |
626-P | QUALITY OF EVIDENCE-BASED GUIDELINES FOR TRANSFUSION OF RED BLOOD CELLS AND PLASMA: A SYSTEMATIC REVIEW | Denise Landry | Received |
629-P | SICKLE CELL DISEASE: THE ADVANTAGES OF PHENOTYPE COMPATIBLE RED CELLS AND UTILITY OF GENOTYPING IN ERTHROCYTAPHERESIS | Danielle Clucas | Received |
634-P | TRANSFUSION REQUIREMENTS OF PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TANSPLANTATION FROM DIFFERENT STEM CELL SOURCES AND MODALITIES | Pilar Solves | Received |
642-P | APPROPRIATENESS OF PLATELET USE IN MATER DEI HOSPITAL, MALTA | Denise Borg-Aquilina | Received |
645-P | RED CELL SPECIFICATIONS FOR PATIENTS WITH HEMOGLOBINOPATHIES: A SYSTEMATIC REVIEW AND GUIDELINE | Denise Landry | Received |
657-P | MASSIVE TRANSFUSION: FEEDBACK ON PRACTICE THROUGH HOSPITAL DATA REPORTS PROVIDES OPPORTUNITIES FOR PRACTICE IMPROVEMENT AND BENCHMARKING | Erica Wood | Received |
668-P | CHALLENGES IN THE EVALUATION OF RECIPIENT PULMONARY EVENTS--THE EXPERIENCE OF A LARGE COLLECTION ORGANIZATION | Mary Townsend | Received |
683-P | HAEMOLYTIC DISEASE OF FOETUS AND NEWBORN (HDFN) AND HAEMOLYTIC TRANSFUSION REACTION DUE TO KIDD ANTIBODY IN HOSPITAL UMUM SARAWAK, MALAYSIA. | Irni Mohd Yasin | Received |
699-P | THE FIRST PRELIMINARY STEP TOWARDS NATIONAL HEMOVIGILANCE IN LEBANON | Antoine HADDAD | Received |
17-21 June 2017 Copenhagen
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|